The relationship between crystalline methamphetamine use and methamphetamine dependence

Drug and Alcohol Dependence

Volumn 85, Issue 3, 2006, Pages 198-204

  McKetin, Rebecca ^a   Kelly, Erin ^a   McLaren, Jennifer ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Crystalline methamphetamine; Dependence; Drug; Duration; Injecting; Methamphetamine; Route of administration; Smoking

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DEMOGRAPHY; DISEASE SEVERITY; DRUG ABUSE PATTERN; DRUG DEPENDENCE; FEMALE; HUMAN; INJECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PHOTOGRAPHY; PRIORITY JOURNAL; SAMPLE; SMOKING; VALIDATION PROCESS;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 33750517562     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.04.007     Document Type: Article

References (42)

1. Barrio G., De La Fuente L., Lew C., Royuela L., Bravo M.J., and Torrens M. Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. Drug Alcohol Depend. 63 (2001) 169-177
2. Carroll M.E., and Lac S.T. Acquisition of i.v. amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology (Berl) 129 (1997) 206-214
3. Cho A.K. Ice: a new dosage form of an old drug. Science 249 (1990) 631-634
4. Cho A.K., and Melega W.P. Patterns of methamphetamine abuse and their consequences. J. Addict. Dis. 21 (2002) 21-34
5. Cicchetti D., and Rogosch F.A. Psychopathology as risk for adolescent substance use disorders: a developmental psychopathology perspective. J. Clin. Child Psychol. 28 (1999) 355-365
6. Cook C.E., Jeffcoat A.R., Hill J.M., Pugh D.E., Patetta P.K., Sadler B.M., White W.R., and Perez-Reyes M. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking s-(+)-methamphetamine hydrochloride. Drug Metab. Dispos. 21 (1993) 717-723
7. Crofts N., Louie R., Rosenthal D., and Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction 91 (1996) 1187-1196
8. Darke S., Cohen J., Ross J., Hando J., and Hall W. Transitions between routes of administration of regular amphetamine users. Addiction 89 (1994) 1077-1083
9. Farrell M., Boys A., Bebbington P., Brugha T., Coid J., Jenkins R., Lewis G., Meltzer H., Marsden J., Singleton N., and Taylor C. Psychosis and drug dependence: Results from a national survey of prisoners. Br. J. Psychiatry 181 (2002) 393-398
10. Farrell M., Marsden J., Ali R., and Ling W. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 97 (2002) 771-772
11. Fuller C.M., Vlahov D., Ompad D.C., Shah N., Arria A., and Strathdee S.A. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 66 (2002) 189-198
12. Glantz M.D., and Pickens R. Vulnerability to Drug Abuse (1992), American Psychological Association, Washington
13. Goeders N.E. The impact of stress on addiction. Eur. Neuropsychopharmacol. 13 (2003) 435-441
14. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., and Strang J. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90 (1995) 607-614
15. Gossop M., Griffiths P., Powis B., and Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br. J. Addict. 87 (1992) 1527-1536
16. Greenwell L., and Brecht M.-L. Self-reported health status among treated methamphetamine users. Am. J. Drug Alcohol Abuse 29 (2003) 75-104
17. Hall W., and Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev. 13 (1994) 277-284
18. Hall W., Hando J., Darke S., and Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 91 (1996) 81-87
19. Jernigan T., Gamst A., Archibald S., Fennema-Notestine C., Mindt M., Marcotte T., Heaton R., Ellis R., and Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am. J. Psychiatry 162 (2005) 1461-1472
20. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162 (2005) 1403-1413
21. Karch S.B., Stephens B.G., and Ho C.H. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicological profiles. J. Forensic Sci. 44 (1999) 359-368
22. Kendler K.S., Jacobson K.C., Prescott C.A., and Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am. J. Psychiatry 160 (2003) 687-695
23. Matsumoto T., Kamijo A., Miyakawa T., Endo K., Yabana T., Kishimoto H., Okudaira K., Iseki E., Sakai T., and Kosaka K. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 97 (2002) 809-817
24. McKetin, R., McLaren, J., Kelly, E., 2005. The dynamics of the Sydney methamphetamine market: an overview of supply, use patterns, personal harms and social consequences. National Drug Law Enforcement Monograph Series No. 13. Australasian Centre for Policing Research, Adelaide.
25. McKetin, R., McLaren, J., Lubman, D., Hides, L., in press. The prevalence of psychotic symptoms among methamphetamine users. Addiction.
26. Molitor F., Truax S.R., Ruiz J.D., and Sun R.K. Association of methamphetamine use during sex with risky sexual behaviours and HIV infection among non-injection drug users. West. J. Med. 168 (1998) 93-97
27. Neaigus A., Miller M., Friedman S.R., Hagen D.L., Sifaneck S.J., Ildefonso G., and des Jarlais D.C. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 96 (2001) 847-860
28. Nordahl T., Salo R., and Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J. Neuropsychiatry Clin. Neurosci. 15 (2003) 317-325
29. Parry C., Myers B., and Plüddemann A. Drug policy for methamphetamine use urgently needed. S. Afr. Med. J. 94 (2004) 964-965
30. Patton L.H. Adolescent substance abuse. Risk factors and protective factors. Pediatr. Clin. North Am. 42 (1995) 283-293
31. Rawson R., Gonzalez R., and Brethen P. Treatment of methamphetamine use disorders: an update. J. Subst. Abuse Treat. 23 (2002) 145-150
32. Roehr B. Half a million Americans use methamphetamine every week. Br. Med. J. 331 (2005) 476
33. Samaha A.-N., and Robinson T.E. Why does the rapid delivery of drugs to the brain promote addiction?. Trends Pharmacol. Sci. 26 (2005) 82-87
34. Strang J., Griffiths P., Powis B., and Gossop M. First use of heroin: changes in the route of administration over time. Br. Med. J. 304 (1992) 1222-1223
35. Strang J., Griffiths P., Powis B., and Gossop M. Heroin chasers and heroin injectors. Differences observed in a community sample in London, UK. Am. J. Addict. 8 (1999) 148-160
36. Tohhara S., Kato A., and Nakajima T. Methamphetamine abuse by smoking. Arukoru Kenkyu-To Yakubutsu Ison. Jpn. J. Alcohol Stud. Drug Depen. 25 (1990) 467-474
37. Topp L., Degenhardt L., Kaye S., and Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. Drug Alcohol Rev. 21 (2002) 341-348
38. Topp L., and Mattick R.P. Choosing a cutoff on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 92 (1997) 839-845
39. United Nations Office on Drugs and Crime. Patterns and Trends in Amphetamine-Type Stimulants in East Asia and the Pacific: Findings from the 2004 Regional ATS Questionnaire (2005), United Nations Office on Drugs and Crime Regional Centre for East Asia and the Pacific, Bangkok
40. Volkow N.D., and Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 160 (2003) 1909-1918
41. Volkow N.D., Wang G.J., Fischman M.W., Foltin R., Fowler J.S., Franceschi D., Franceschi M., Logan J., Gatley S.J., Wong C., Ding Y.S., Hitzemann R., and Pappas N. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci. 67 (2000) 1507-1515
42. Woods S., Rippeth J., Conover E., Gongvatana A., Gonzalez R., Carey C., Cherner M., Heaton R., and Grant I. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 19 (2005) 35-43